Joao Pedro Ferreira (João Pedro Ferreira, J P Ferreira)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 90

Top Venues

European journal of heart failure

Diabetes, obesity & metabolism

European heart journal

Journal of the American Heart Association

Université de Lorraine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Université de Lorraine

France

MD, PhD :: CIC-P

Publications

Joao Pedro Ferreira, Faiez Zannad, Milton Packer, Gerasimos Filippatos, Stuart J Pocock, Francisco Vasques-Nóvoa, Michael Böhm, Javed Butler, Stefan Anker
Empagliflozin and risk of lower respiratory tract infection in heart failure with mildly reduced and preserved ejection fraction: An EMPEROR-Preserved analysis. European journal of heart failure 26 (4) (2024)
Faiez Zannad, Joao Pedro Ferreira
Proteomics for understanding progression to heart failure in chronic kidney disease: promising but still not there. European heart journal 45 (30) (2024)
Joao Pedro Ferreira, Faiez Zannad, Milton Packer, Gerasimos Filippatos, Stuart J Pocock, Francisco Vasques-Nóvoa, Michael Böhm, Javed Butler, Stefan Anker
Empagliflozin and risk of lower respiratory tract infection in heart failure with mildly reduced and preserved ejection fraction: An EMPEROR-Preserved analysis. European journal of heart failure (2024)
Joao Pedro Ferreira, Jonathan P Blatchford, John R Teerlink, Mikhail N Kosiborod, Christiane E Angermann, Jan Biegus, Sean P Collins, Jasper Tromp, Michael E Nassif, Mitchell A Psotka, Josep Comin-Colet, Robert J Mentz, Martina Brueckmann, Matias Nordaby, Piotr Ponikowski, Adriaan A Voors
Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSE. European journal of heart failure (2024)
Khawaja M Talha, Jennifer Green, Gerasimos Filippatos, Stuart Pocock, Faiez Zannad, Martina Brueckmann, Elke Schueler, Anne Pernille Ofstad, Joao Pedro Ferreira, Stefan D Anker, Javed Butler, Julio Rosenstock, Milton Packer
Impact of empagliflozin on insulin needs in patients with heart failure and diabetes: An EMPEROR-Pooled analysis. Diabetes, obesity & metabolism 26 (7) (2024)
Faiez Zannad, Joao Pedro Ferreira
Proteomics for understanding progression to heart failure in chronic kidney disease: promising but still not there. European heart journal (2024)
Amir Razaghizad, Jiayi Ni, Pedro Marques, Thomas A Mavrakanas, Michael A Tsoukas, Elite Possik, Thao Huynh, Jodi D Edwards, Peter Liu, Walter Swardfager, Frederic Baroz, Joao Pedro Ferreira, Abhinav Sharma
Cardiovascular phenotypes in type 2 diabetes: Latent class analysis of the CANVAS Program and CREDENCE trial. Diabetes, obesity & metabolism (2024)
Faiez Zannad, Joao Pedro Ferreira
Proteomics for understanding progression to heart failure in chronic kidney disease: promising but still not there. European heart journal 45 (30) (2024)
Joao Pedro Ferreira, Faiez Zannad, Milton Packer, Gerasimos Filippatos, Stuart J Pocock, Francisco Vasques-Nóvoa, Michael Böhm, Javed Butler, Stefan Anker
Empagliflozin and risk of lower respiratory tract infection in heart failure with mildly reduced and preserved ejection fraction: An EMPEROR-Preserved analysis. European journal of heart failure 26 (4) (2024)
Joao Pedro Ferreira, Adriaan A Voors
Reply to 'Empagliflozin and glucagon-like peptide-1 receptor agonists: The brothers for heart failure?' European journal of heart failure (2024)
Khawaja M Talha, Jennifer Green, Gerasimos Filippatos, Stuart Pocock, Faiez Zannad, Martina Brueckmann, Elke Schueler, Anne Pernille Ofstad, Joao Pedro Ferreira, Stefan D Anker, Javed Butler, Julio Rosenstock, Milton Packer
Impact of empagliflozin on insulin needs in patients with heart failure and diabetes: An EMPEROR-Pooled analysis. Diabetes, obesity & metabolism (2024)
Fang-Fei Wei, Pierpaolo Pellicori, Joao Pedro Ferreira, Arantxa González, Beatrice Mariottoni, De-Wei An, Job A J Verdonschot, Chen Liu, Fozia Z Ahmed, Johannes Petutschnigg, Patrick Rossignol, Stephane R B Heymans, Joe Cuthbert, Nicholas Girerd, Andrew L Clark, Yan Li, Tim S Nawrot, Javier Díez, Faiez Zannad, John G F Cleland, Jan A Staessen, null null
Effects of spironolactone on exercise blood pressure in patients at increased risk of developing heart failure: report from the HOMAGE trial. Hypertension research : official journal of the Japanese Society of Hypertension (2024)
Khawaja M Talha, Jennifer Green, Gerasimos Filippatos, Stuart Pocock, Faiez Zannad, Martina Brueckmann, Elke Schueler, Anne Pernille Ofstad, Joao Pedro Ferreira, Stefan D Anker, Javed Butler, Julio Rosenstock, Milton Packer
Impact of empagliflozin on insulin needs in patients with heart failure and diabetes: An EMPEROR-Pooled analysis. Diabetes, obesity & metabolism 26 (7) (2024)
Yu-Ling Yu, Justyna Siwy, De-Wei An, Arantxa González, Tine Hansen, Agnieszka Latosinska, Pierpaolo Pellicori, Susana Ravassa, Beatrice Mariottoni, Job A J Verdonschot, Fozia Ahmed, Johannes Petutschnigg, Patrick Rossignol, Stephane Heymans, Joe J Cuthbert, Nicolas Girerd, Andrew L Clark, Peter Verhamme, Tim S Nawrot, Stefan Janssens, John G F Cleland, Faiez Zannad, Javier Diez, Harald Mischak, Joao Pedro Ferreira, Jan A Staessen, null null
Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial. Heart (British Cardiac Society) (2024)
Nicholas Girerd, Daniel Levy, Kévin Duarte, Joao Pedro Ferreira, Christie M Ballantyne, Stuart J Pocock, Anne Pizard, Jens Björkman, Javed Butler, Andrew L Clark, John G Cleland, Christian Delles, Javier Diez, Arantxa González, Mark R Hazebroek, Jennifer E Ho, Anne-Cécile Huby, Shih-Jen Hwang, Roberto Latini, Beatrice Mariottoni, Alexandre Mebazaa, Pierpaolo Pellicori, Naveed Sattar, Peter Sever, Jan A Staessen, Job A J Verdonschot, Stephane R B Heymans, Patrick Rossignol, Faiez Zannad
Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study. Circulation. Heart failure 16 (5) (2023)
Maria Betânia Ferreira, M Kobayashi, R Q Costa, T Fonseca, M Brandão, J C Oliveira, A Marinho, H Cyrne Carvalho, P Rodrigues, F Zannad, P Rossignol, A S Barros, Joao Pedro Ferreira
Unsupervised clustering to differentiate rheumatoid arthritis patients based on proteomic signatures. Scandinavian journal of rheumatology (2023)
Joao Pedro Ferreira, Milton Packer, Javed Butler, Gerasimos Filippatos, Stuart J Pocock, James L Januzzi, Naveed Sattar, Sandra González Maldonado, Marina Panova-Noeva, Mikhail Sumin, Serge Masson, Stefan D Anker, Faiez Zannad
GDF-15 and the Effect of Empagliflozin in Heart Failure: Findings from the EMPEROR Program. European journal of heart failure (2023)
Milton Packer, Javed Butler, Cordula Zeller, Stuart J Pocock, Martina Brueckmann, Joao Pedro Ferreira, Gerasimos S Filippatos, Muhammad Shariq Usman, Faiez Zannad, Stefan D Anker
Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure. Circulation (2023)
Maria Betânia Ferreira, M Kobayashi, R Q Costa, T Fonseca, M Brandão, J C Oliveira, A Marinho, H Cyrne Carvalho, P Rodrigues, F Zannad, P Rossignol, A S Barros, Joao Pedro Ferreira
Unsupervised clustering to differentiate rheumatoid arthritis patients based on proteomic signatures. Scandinavian journal of rheumatology (2023)
Nicholas Girerd, Daniel Levy, Kévin Duarte, Joao Pedro Ferreira, Christie M Ballantyne, Stuart J Pocock, Anne Pizard, Jens Björkman, Javed Butler, Andrew L Clark, John G Cleland, Christian Delles, Javier Diez, Arantxa González, Mark R Hazebroek, Jennifer E Ho, Anne-Cécile Huby, Shih-Jen Hwang, Roberto Latini, Beatrice Mariottoni, Alexandre Mebazaa, Pierpaolo Pellicori, Naveed Sattar, Peter Sever, Jan A Staessen, Job A J Verdonschot, Stephane R B Heymans, Patrick Rossignol, Faiez Zannad
Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study. Circulation. Heart failure 16 (5) (2023)
Joao Pedro Ferreira, Abhinav Sharma, Javed Butler, Milton Packer, Faiez Zannad, Francisco Vasques-Nóvoa, Adelino Leite-Moreira, João Sérgio Neves
Glucagon-like peptide-1 receptor agonists across the spectrum of heart failure. The Journal of clinical endocrinology and metabolism (2023)
Maria Betânia Ferreira, M Kobayashi, R Q Costa, T Fonseca, M Brandão, J C Oliveira, A Marinho, H Cyrne Carvalho, P Rodrigues, F Zannad, P Rossignol, A S Barros, Joao Pedro Ferreira
Unsupervised clustering to differentiate rheumatoid arthritis patients based on proteomic signatures. Scandinavian journal of rheumatology (2023)
Joao Pedro Ferreira, Francisca A Saraiva, Abhinav Sharma, Francisco Vasques-Nóvoa, António Angélico-Gonçalves, Ana Rita Leite, Marta Borges-Canha, Davide Carvalho, Milton Packer, Faiez Zannad, Adelino Leite-Moreira, João Sérgio Neves
Glucagon-like peptide 1 receptor agonists in patients with type 2 diabetes with and without chronic heart failure: a meta-analysis of randomized placebo-controlled outcome trials. Diabetes, obesity & metabolism (2023)
Marli Cruz, Joao Pedro Ferreira, Silvia O Diaz, Diana Ferrão, Ana Isabel Ferreira, Nicolas Girerd, Francisco Sampaio, Joana Pimenta
Lung ultrasound and diuretic therapy in chronic heart failure: a randomised trial. Clinical research in cardiology : official journal of the German Cardiac Society (2023)
Joao Pedro Ferreira, Javed Butler, Stefan D Anker, James L Januzzi, Marina Panova-Noeva, Alexander L Reese-Petersen, Naveed Sattar, Elke Schueler, Stuart J Pocock, Gerasimos Filippatos, Milton Packer, Mikhail Sumin, Faiez Zannad, null null
Effects of empaglifozin on collagen biomarkers in patients with Heart Failure. Findings from the EMPEROR trials. European journal of heart failure (2023)
Joao Pedro Ferreira, Francisca A Saraiva, Abhinav Sharma, Francisco Vasques-Nóvoa, António Angélico-Gonçalves, Ana Rita Leite, Marta Borges-Canha, Davide Carvalho, Milton Packer, Faiez Zannad, Adelino Leite-Moreira, João Sérgio Neves
Glucagon-like peptide 1 receptor agonists in patients with type 2 diabetes with and without chronic heart failure: A meta-analysis of randomized placebo-controlled outcome trials. Diabetes, obesity & metabolism (2023)
Joao Pedro Ferreira, João Sérgio Neves
Response to Letter to Editor from Banerjee et al.: "Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure". The Journal of clinical endocrinology and metabolism (2023)
Joao Pedro Ferreira, Tiago Taveira-Gomes, Mariana Canelas-Pais, Phillip Phan, Filipa Bernardo, Karolina Andersson Sundell, Mário Almeida, Hugo Martinho, Cristina Gavina
Missed opportunities in the diagnosis of heart failure: a real-world assessment. ESC heart failure (2023)
Joao Pedro Ferreira, Jonathan P Blatchford, John R Teerlink, Mikhail N Kosiborod, Christiane E Angermann, Jan Biegus, Sean P Collins, Jasper Tromp, Michael E Nassif, Mitchell A Psotka, Josep Comin-Colet, Robert J Mentz, Martina Brueckmann, Matias Nordaby, Piotr Ponikowski, Adriaan A Voors
Mineralocorticoid receptor antagonist use and the effects of empagliflozin on clinical outcomes in patients admitted for acute heart failure: findings from EMPULSE. European journal of heart failure (2023)
Nicholas Girerd, Daniel Levy, Kévin Duarte, Joao Pedro Ferreira, Christie M Ballantyne, Stuart J Pocock, Anne Pizard, Jens Björkman, Javed Butler, Andrew L Clark, John G Cleland, Christian Delles, Javier Diez, Arantxa González, Mark R Hazebroek, Jennifer E Ho, Anne-Cécile Huby, Shih-Jen Hwang, Roberto Latini, Beatrice Mariottoni, Alexandre Mebazaa, Pierpaolo Pellicori, Naveed Sattar, Peter Sever, Jan A Staessen, Job A J Verdonschot, Stephane R B Heymans, Patrick Rossignol, Faiez Zannad
Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study. Circulation. Heart failure 16 (5) (2023)
Michael Böhm, Stefan D Anker, Felix Mahfoud, Lucas Lauder, Gerasimos S Filippatos, Joao Pedro Ferreira, Stuart J Pocock, Martina Brueckmann, Ilias Saloustros, Elke Schüler, Christoph Wanner, Faiez Zannad, Milton Packer, Javed Butler
Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial. European heart journal (2022)
Muhammad Shahzeb Khan, Javed Butler, Stefan D Anker, Gerasimos S Filippatos, Joao Pedro Ferreira, Stuart J Pocock, James L Januzzi, Iliana L Piña, Michael Böhm, Piotr Ponikowski, Subodh Verma, Martina Brueckmann, Ola Vedin, Cordula Zeller, Faiez Zannad, Milton Packer
Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause. Journal of the American Heart Association 12 (1) (2022)
Joao Pedro Ferreira, John G F Cleland, Nicolas Girerd, Pierpaolo Pellicori, Mark R Hazebroek, Job Verdonschot, Timothy J Collier, Johannes Petutschnigg, Andrew L Clark, Jan A Staessen, Stephane Heymans, Faiez Zannad, Patrick Rossignol
Early and late renal function changes with spironolactone in patients at risk of developing heart failure: findings from the HOMAGE trial. Clinical research in cardiology : official journal of the German Cardiac Society (2022)
Muhammad Shahzeb Khan, Javed Butler, Stefan D Anker, Gerasimos S Filippatos, Joao Pedro Ferreira, Stuart J Pocock, James L Januzzi, Iliana L Piña, Michael Böhm, Piotr Ponikowski, Subodh Verma, Martina Brueckmann, Ola Vedin, Cordula Zeller, Faiez Zannad, Milton Packer
Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause. Journal of the American Heart Association 12 (1) (2022)
Joao Pedro Ferreira, John G Cleland, Nicolas Girerd, Erwan Bozec, Patrick Rossignol, Pierpaolo Pellicori, Franco Cosmi, Beatrice Mariottoni, Scott D Solomon, Bertram Pitt, Marc A Pfeffer, Amil M Shah, Johannes Petutschnigg, Burkert Pieske, Frank Edelmann, Faiez Zannad
Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: a pooled analysis of three randomized trials. European journal of heart failure (2022)
Wassim Bedrouni, Abhinav Sharma, Bertram Pitt, Carolyn Su Ping Lam, Jiayi Ni, Joao Pedro Ferreira, John Joseph Valentine McMurray, Nadia Giannetti, Nicolas Girerd, Patrick Rossignol, Scott D Solomon, Brian Lee Claggett, Stuart Pocock, Thao Huynh, Faiez Zannad
Timing of Statistical Benefit of Mineralocorticoid Receptor Antagonists Among Patients With Heart Failure and Post-Myocardial Infarction. Circulation. Heart failure 15 (10) (2022)
Stuart J Pocock, Joao Pedro Ferreira, Milton Packer, Faiez Zannad, Gerasimos Filippatos, Toru Kondo, John J V McMurray, Scott D Solomon, James L Januzzi, Tomoko Iwata, Afshin Salsali, Javed Butler, Stefan D Anker
Biomarker-driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR-Preserved trial. European journal of heart failure 24 (10) (2022)
João Sérgio Neves, Francisco Vasques-Nóvoa, Marta Borges-Canha, Ana Rita Leite, Abhinav Sharma, Davide Carvalho, Milton Packer, Faiez Zannad, Adelino Leite-Moreira, Joao Pedro Ferreira
Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: A post hoc analysis of the FIGHT trial. Diabetes, obesity & metabolism (2022)
Joao Pedro Ferreira, Ana Leite, António Gonçalves, Marta Canha, João Sérgio Neves
Letter of reply to the letter by Ryan. Diabetes, obesity & metabolism 24 (8) (2022)
Albert Henry, Maria Gordillo-Marañón, Chris Finan, Amand F Schmidt, Joao Pedro Ferreira, Ravi Karra, Johan Sundström, Lars Lind, Johan Ärnlöv, Faiez Zannad, Anders Mälarstig, Aroon D Hingorani, R Thomas Lumbers, null null
Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization. Circulation 145 (16) (2022)
Muhammad Shahzeb Khan, Javed Butler, Stefan D Anker, Gerasimos S Filippatos, Joao Pedro Ferreira, Stuart J Pocock, James L Januzzi, Iliana L Piña, Michael Böhm, Piotr Ponikowski, Subodh Verma, Martina Brueckmann, Ola Vedin, Cordula Zeller, Faiez Zannad, Milton Packer
Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause. Journal of the American Heart Association 12 (1) (2022)
Muhammad Shahzeb Khan, Javed Butler, Stefan D Anker, Gerasimos S Filippatos, Joao Pedro Ferreira, Stuart J Pocock, James L Januzzi, Iliana L Piña, Michael Böhm, Piotr Ponikowski, Subodh Verma, Martina Brueckmann, Ola Vedin, Cordula Zeller, Faiez Zannad, Milton Packer
Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause. Journal of the American Heart Association 12 (1) (2022)
Joao Pedro Ferreira, Wouter Ouwerkerk, Bernadet T Santema, Dirk J van Veldhuisen, Chim C Lang, Leong L Ng, Stefan D Anker, Kenneth Dickstein, Marco Metra, John G F Cleland, Samani J Nilesh, Gerasimos S Filippatos, Joseph-Pierre Aboumsallem, Rudolf A de Boer, Sylwia Figarska, Iziah E Sama, Adriaan A Voors, Faiez Zannad
Differences in biomarkers and molecular pathways according to age for patients with HFrEF. Cardiovascular research 117 (10) (2022)
Subodh Verma, Nitish K Dhingra, Javed Butler, Stefan D Anker, Joao Pedro Ferreira, Gerasimos S Filippatos, James L Januzzi, Carolyn Su Ping Lam, Naveed Sattar, Egon Pfarr, Matias Nordaby, Martina Brueckmann, Stuart J Pocock, Faiez Zannad, Milton Packer
Empagliflozin in Black Versus White Patients with Heart Failure: Analysis of EMPEROR-Pooled. Circulation (2022)
Amir Razaghizad, Abhinav Sharma, Jiayi Ni, Joao Pedro Ferreira, William B White, Cyrus R Mehta, George L Bakris, Faiez Zannad
External validation and extension of the TIMI risk score for heart failure in diabetes for patients with recent acute coronary syndrome: An analysis of the EXAMINE trial. Diabetes, obesity & metabolism (2022)
Muhammad Shahzeb Khan, Javed Butler, Stefan D Anker, Gerasimos S Filippatos, Joao Pedro Ferreira, Stuart J Pocock, James L Januzzi, Iliana L Piña, Michael Böhm, Piotr Ponikowski, Subodh Verma, Martina Brueckmann, Ola Vedin, Cordula Zeller, Faiez Zannad, Milton Packer
Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause. Journal of the American Heart Association (2022)
Amir Razaghizad, Emily Oulousian, Varinder Kaur Randhawa, Joao Pedro Ferreira, James M Brophy, Stephen J Greene, Julian Guida, G Michael Felker, Marat Fudim, Michael Tsoukas, Tricia M Peters, Thomas A Mavrakanas, Nadia Giannetti, Justin A Ezekowitz, Abhinav Sharma
Clinical Prediction Models for Heart Failure Hospitalization in Type 2 Diabetes: A Systematic Review and Meta-Analysis. Journal of the American Heart Association 11 (10) (2022)
Ana Rita Leite, António Angélico-Gonçalves, Francisco Vasques-Nóvoa, Marta Borges-Canha, Adelino F Leite-Moreira, João Sérgio Neves, Joao Pedro Ferreira
Effect of glucagon-like peptide-1 receptor agonists on cardiovascular events in overweight or obese adults without diabetes: A meta-analysis of placebo-controlled randomized trials. Diabetes, obesity & metabolism 24 (8) (2022)
Mikhail Naum Kosiborod, Christiane E Angermann, Sean P Collins, John R Teerlink, Piotr Ponikowski, Jan Biegus, Josep Comín Colet, Joao Pedro Ferreira, Robert J Mentz, Michael E Nassif, Mitchell A Psotka, Jasper Tromp, Martina Brueckmann, Jonathan P Blatchford, Afshin Salsali, Carolyn S P Lam
Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial. Circulation 146 (4) (2022)
Joao Pedro Ferreira, Francisco Vasques-Nóvoa, Diana Ferrão, Francisca Saraiva, Inês Falcão-Pires, João Sérgio Neves, Abhinav Sharma, Patrick Rossignol, Faiez Zannad, Adelino Leite-Moreira
Fenofibrate and Heart Failure Outcomes in Patients With Type 2 Diabetes: Analysis From ACCORD. Diabetes care 45 (7) (2022)
Joao Pedro Ferreira, João Sérgio Neves
Letter regarding the article 'Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial. European journal of heart failure (2022)
Mehmet Kanbay, Constance Xhaard, Edith Le Floch, Claire Dandine-Roulland, Nicolas Girerd, Joao Pedro Ferreira, Jean-Marc Boivin, Sandra Wagner, Delphine Bacq-Daian, Jean-François Deleuze, Faiez Zannad, Patrick Rossignol
Weak Association Between Genetic Markers of Hyperuricemia and Cardiorenal Outcomes: Insights From the STANISLAS Study Cohort With a 20-Year Follow-Up. Journal of the American Heart Association 11 (9) (2022)
Joao Pedro Ferreira, João Sérgio Neves
Glucagon-like peptide 1 receptor agonists in heart failure: the need for a rewind. European journal of heart failure 24 (10) (2022)
Muhammad Shahzeb Khan, Javed Butler, Stefan D Anker, Gerasimos S Filippatos, Joao Pedro Ferreira, Stuart J Pocock, James L Januzzi, Iliana L Piña, Michael Böhm, Piotr Ponikowski, Subodh Verma, Martina Brueckmann, Ola Vedin, Cordula Zeller, Faiez Zannad, Milton Packer
Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause. Journal of the American Heart Association 12 (1) (2022)
Javed Butler, Gerasimos S Filippatos, Tariq Jamal Siddiqi, Joao Pedro Ferreira, Martina Brueckmann, Edimar Alcides Bocchi, Michael Böhm, Vijay K Chopra, Nadia Giannetti, Tomoko Iwata, James L Januzzi, Sanjay Kaul, Iliana L Piña, Piotr Ponikowski, Ursula Rauch, Sanjiv J Shah, Michele Senni, Mikhail Sumin, Subodh Verma, Jian Zhang, Stuart J Pocock, Faiez Zannad, Milton Packer, Stefan D Anker
Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction. Circulation 146 (14) (2022)
Joao Pedro Ferreira, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Tomoko Iwata, Afshin Salsali, Cordula Zeller, Stuart J Pocock, Faiez Zannad, Milton Packer
Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR-Reduced. European journal of heart failure 24 (4) (2022)
Joao Pedro Ferreira, Abhinav Sharma, Francisco Vasques-Nóvoa, António Angélico-Gonçalves, Ana Rita Leite, Marta Borges-Canha, Davide Carvalho, Milton Packer, Faiez Zannad, Adelino Leite-Moreira, João Sérgio Neves
Albiglutide in patients with type 2 diabetes and heart failure: a post-hoc analysis from Harmony Outcomes. European journal of heart failure 24 (10) (2022)
Joao Pedro Ferreira, Faiez Zannad, Javed Butler, Gerasimos Filipattos, Ivana Ritter, Elke Schüler, Bettina J Kraus, Stuart J Pocock, Stefan D Anker, Milton Packer
Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled. European heart journal 43 (31) (2022)
Gerasimos S Filippatos, Javed Butler, Dimitrios Farmakis, Faiez Zannad, Anne Pernille Ofstad, Joao Pedro Ferreira, Jennifer B Green, Julio Rosenstock, Sven Schnaidt, Martina Brueckmann, Stuart J Pocock, Milton Packer, Stefan D Anker, null null
Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes. Circulation 146 (9) (2022)
Muhammad Shahzeb Khan, Javed Butler, Stefan D Anker, Gerasimos S Filippatos, Joao Pedro Ferreira, Stuart J Pocock, James L Januzzi, Iliana L Piña, Michael Böhm, Piotr Ponikowski, Subodh Verma, Martina Brueckmann, Ola Vedin, Cordula Zeller, Faiez Zannad, Milton Packer
Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause. Journal of the American Heart Association 12 (1) (2022)
Masatake Kobayashi, Adriaan A Voors, Wouter Ouwerkerk, Kevin Duarte, Nicolas Girerd, Patrick Rossignol, Marco Metra, Chim C Lang, Leong L Ng, Gerasimos Filippatos, Kenneth Dickstein, Dirk J van Veldhuisen, Faiez Zannad, Joao Pedro Ferreira
Perceived risk profile and treatment optimization in heart failure: an analysis from BIOlogy Study to TAilored Treatment in chronic heart failure. Clinical cardiology 44 (6) (2021)
Stuart J Pocock, Joao Pedro Ferreira, John Gregson, Stefan D Anker, Javed Butler, Gerasimos S Filippatos, Nicholas D Gollop, Tomoko Iwata, Martina Brueckmann, James L Januzzi, Adriaan A Voors, Faiez Zannad, Milton Packer
Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trial. European heart journal 42 (43) (2021)
Joao Pedro Ferreira, John Gregson, Michael Böhm, Patrick Rossignol, Faiez Zannad, Stuart J Pocock
Blood pressure reduction and anti-hypertensive treatment choice: A post-hoc analysis of the SPRINT trial. Clinical cardiology 44 (5) (2021)
Joao Pedro Ferreira, Ana Cristina Oliveira, Francisca A Saraiva, Francisco Vasques-Nóvoa, Adelino Leite-Moreira
Sodium-glucose co-transporter inhibitors in insulin-treated diabetes: a meta-analysis. European journal of endocrinology 184 (6) (2021)
Carolyn Su Ping Lam, Joao Pedro Ferreira, Egon Pfarr, David Sim, Hiroyuki Tsutsui, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Stuart J Pocock, Naveed Sattar, Subodh Verma, Martina Brueckmann, Janet Schnee, Daniel Cotton, Faiez Zannad, Milton Packer
Regional and ethnic influences on the response to empagliflozin in patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial. European heart journal 42 (43) (2021)
Joao Pedro Ferreira, Michael Böhm, Patrick Rossignol, Faiez Zannad
Impact of Anti-hypertensive Therapy in the Sexual Health of Men and Women: An Analysis From the SPRINT Trial. American journal of hypertension 34 (7) (2021)
Bertram Pitt, Joao Pedro Ferreira, Faiez Zannad
Why are mineralocorticoid receptor antagonists the Cinderella in evidence-based treatment of myocardial infarction complicated with heart failure? Lessons from PARADISE-MI. European heart journal (2021)
Joao Pedro Ferreira, John G Cleland, Carolyn S P Lam, Stefan D Anker, Mandeep R Mehra, Dirk J van Veldhuisen, William M Byra, David A La Police, Bertram Pitt, Barry Greenberg, Faiez Zannad
Heart failure re-hospitalizations and subsequent fatal events in coronary artery disease: insights from COMMANDER-HF, EPHESUS, and EXAMINE. Clinical research in cardiology : official journal of the German Cardiac Society 110 (10) (2021)
Joao Pedro Ferreira, Patrick Rossignol, George Bakris, Cyrus Mehta, William B White, Faiez Zannad
Body weight changes in patients with type 2 diabetes and a recent acute coronary syndrome: an analysis from the EXAMINE trial. Cardiovascular diabetology 20 (1) (2021)
Luca Monzo, Joao Pedro Ferreira, Zohra Lamiral, Erwan Bozec, Jean-Marc Boivin, Olivier Huttin, Marilucy Lopez-Sublet, Nicolas Girerd, Faiez Zannad, Patrick Rossignol
Isolated diastolic hypertension and target organ damage: Findings from the STANISLAS cohort. Clinical cardiology 44 (11) (2021)
Javed Butler, Stefan D Anker, Gerasimos S Filippatos, Muhammad Shariq Usman, Joao Pedro Ferreira, Faiez Zannad, Milton Packer
Sodium glucose co-transporter inhibitors and heart failure outcomes across different patient populations. European heart journal (2021)
Javed Butler, Gerasimos S Filippatos, Tariq Jamal Siddiqi, Martina Brueckmann, Michael Böhm, Vijay K Chopra, Joao Pedro Ferreira, James L Januzzi, Sanjay Kaul, Iliana L Piña, Piotr Ponikowski, Sanjiv J Shah, Michele Senni, Ola Vedin, Subodh Verma, Barbara Peil, Stuart J Pocock, Faiez Zannad, Milton Packer, Stefan D Anker
Empagliflozin, Health Status, and Quality of Life in Patients with Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial. Circulation (2021)
Malik Elharram, Joao Pedro Ferreira, Thao Huynh, Jiayi Ni, Nadia Giannetti, Subodh Verma, Faiez Zannad, Abhinav Sharma
Prediction of heart failure outcomes in patients with type 2 diabetes mellitus: Validation of the Thrombolysis in Myocardial Infarction Risk Score for Heart Failure in Diabetes (TRS-HFDM ) in patients in the ACCORD trial. Diabetes, obesity & metabolism 23 (3) (2021)
Joao Pedro Ferreira, Jiankang Liu, Brian L Claggett, Orly Vardeny, Bertram Pitt, Marc A Pfeffer, Scott D Solomon, Faiez Zannad
Outpatient diuretic intensification as endpoint in heart failure with preserved ejection fraction trials: an analysis from TOPCAT. European journal of heart failure (2021)
Joao Pedro Ferreira, Diana Ferrao, Patrick Rossignol, Faiez Zannad, Abhinav Sharma, Francisco Vasques-Novoa, Adelino Leite-Moreira
Interplay between worsening kidney function and cardiovascular events in patients with type 2 diabetes: an analysis from the ACCORD trial. BMJ open diabetes research & care 9 (1) (2021)
Joao Pedro Ferreira, John G Cleland, Carolyn S P Lam, Stefan D Anker, Mandeep R Mehra, Dirk J van Veldhuisen, William M Byra, David A LaPolice, Barry Greenberg, Faiez Zannad
New-onset atrial fibrillation in patients with worsening heart failure and coronary artery disease: an analysis from the COMMANDER-HF trial. Clinical research in cardiology : official journal of the German Cardiac Society (2021)
Joao Pedro Ferreira, Catherine M Viscoli, Michaela Mattheus, Thomas Meinicke, Dominik Steubl, Christoph Wanner, Bernard Zinman
Empagliflozin and uric acid metabolism in diabetes: A post hoc analysis of the EMPA-REG OUTCOME trial. Diabetes, obesity & metabolism 24 (1) (2021)
Joao Pedro Ferreira, Zohra Lamiral, George L Bakris, Cyrus Mehta, William B White, Faiez Zannad
Red cell distribution width in patients with diabetes and myocardial infarction: An analysis from the EXAMINE trial. Diabetes, obesity & metabolism 23 (7) (2021)
Javed Butler, Milton Packer, Gerasimos S Filippatos, Joao Pedro Ferreira, Cordula Zeller, Janet Schnee, Martina Brueckmann, Stuart J Pocock, Faiez Zannad, Stefan D Anker
Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction. European heart journal (2021)
Joao Pedro Ferreira, Patrick Rossignol, Faiez Zannad
Renin-angiotensin-aldosterone system and kidney interactions in heart failure. Journal of the renin-angiotensin-aldosterone system : JRAAS 20 (4) (2020)
Joao Pedro Ferreira, Subodh Verma, David Fitchett, Anne Pernille Ofstad, Sabine Lauer, Isabella Zwiener, Jyothis George, Christoph Wanner, Bernard Zinman, Silvio E Inzucchi
Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial. Cardiovascular diabetology 19 (1) (2020)
Joao Pedro Ferreira, Zohra Lamiral, Constance Xhaard, Kévin Duarte, Emmanuel Bresso, Marie-Dominique Devignes, Edith Le Floch, Claire Dandine Roulland, Jean-François Deleuze, Sandra Wagner, Bruno Guerci, Nicolas Girerd, Faiez Zannad, Jean-Marc Boivin, Patrick Rossignol
Circulating plasma proteins and new-onset diabetes in a population-based study: proteomic and genomic insights from the STANISLAS cohort. European journal of endocrinology 183 (3) (2020)
Joao Pedro Ferreira, Abhinav Sharma, Cyrus Mehta, George Bakris, Patrick Rossignol, William B White, Faiez Zannad
Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trial. Clinical research in cardiology : official journal of the German Cardiac Society 110 (7) (2020)
Joao Pedro Ferreira, Anne Pizard, Jean-Loup Machu, Emmanuel Bresso, Hans-Peter Brunner-La Rocca, Nicolas Girerd, Céline Leroy, Arantxa González, Javier Diez, Stephane Heymans, Marie-Dominique Devignes, Patrick Rossignol, Faiez Zannad, null null
Plasma protein biomarkers and their association with mutually exclusive cardiovascular phenotypes: the FIBRO-TARGETS case-control analyses. Clinical research in cardiology : official journal of the German Cardiac Society 109 (1) (2019)
Joao Pedro Ferreira, Kévin Duarte, Holger Woehrle, Martin R Cowie, Christiane Angermann, Marie-Pia d'Ortho, Erland Erdmann, Patrick Levy, Anita K Simonds, Virend K Somers, Helmut Teschler, Karl Wegscheider, Emmanuel Bresso, Marie Dominique-Devignes, Patrick Rossignol, Wolfgang Koenig, Faiez Zannad
Bioprofiles and mechanistic pathways associated with Cheyne-Stokes respiration: insights from the SERVE-HF trial. Clinical research in cardiology : official journal of the German Cardiac Society 109 (7) (2019)
Joao Pedro Ferreira, Xavier Rossello, Bertram Pitt, Patrick Rossignol, Faiez Zannad
Eplerenone in patients with myocardial infarction and "mid-range" ejection fraction: An analysis from the EPHESUS trial. Clinical cardiology 42 (11) (2019)
Joao Pedro Ferreira, António Barros, Bertram Pitt, Gilles Montalescot, Esteban Lopez de Sa, Christian W Hamm, Marcus Flather, Freek Verheugt, Harry Shi, Adelino Leite-Moreira, John Vincent, Patrick Rossignol, Faiez Zannad
Collagen biomarker bioprofiles predicting the antifibrotic response to eplerenone in myocardial infarction: findings from the REMINDER trial. Clinical research in cardiology : official journal of the German Cardiac Society 107 (12) (2018)
Joao Pedro Ferreira, Patrick Rossignol, Anne Pizard, Jean-Loup Machu, Timothy Collier, Nicolas Girerd, Anne-Cécile Huby, Arantxa Gonzalez, Javier Diez, Begoña López, Naveed Sattar, John G Cleland, Peter S Sever, Faiez Zannad
Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure. Heart (British Cardiac Society) 105 (4) (2018)
Joao Pedro Ferreira, Patrick Rossignol, Biniyam Demissei, Abhinav Sharma, Nicolas Girerd, Stefan D Anker, John G Cleland, Kenneth Dickstein, Gerasimos Filippatos, Hans L Hillege, Chim C Lang, Marco Metra, Leong L Ng, Piotr Ponikowski, Nilesh J Samani, Dirk J van Veldhuisen, Aeilko H Zwinderman, Adriaan Voors, Faiez Zannad
Coronary angiography in worsening heart failure: determinants, findings and prognostic implications. Heart (British Cardiac Society) 104 (7) (2017)
Joao Pedro Ferreira, Kévin Duarte, Gilles Montalescot, Bertram Pitt, Esteban Lopez de Sa, Christian W Hamm, Marcus Flather, Freek Verheugt, Harry Shi, Eva Turgonyi, Miguel Orri, Patrick Rossignol, John Vincent, Faiez Zannad
Effect of eplerenone on extracellular cardiac matrix biomarkers in patients with acute ST-elevation myocardial infarction without heart failure: insights from the randomized double-blind REMINDER Study. Clinical research in cardiology : official journal of the German Cardiac Society 107 (1) (2017)
Joao Pedro Ferreira, Mário Santos, Sofia Almeida, Irene Marques, Paulo Bettencourt, Henrique Carvalho
High-sensitivity troponin T: a biomarker for diuretic response in decompensated heart failure patients. Cardiology research and practice 2014 (2014)

Joao Pedro Ferreira.css-eqlu8i{font-size:small;padding-left:4px;} (João Pedro Ferreira, J P Ferreira)

Publication Activity (10 Years)

Top Topics

Top Venues

Joao Pedro Ferreira (João Pedro Ferreira, J P Ferreira)